Comparative Safety of Advanced Therapies for Crohn Disease

JAMA Netw Open. 2026 Feb 2;9(2):e2557922. doi: 10.1001/jamanetworkopen.2025.57922.ABSTRACTIMPORTANCE: With the availability of multiple classes of advanced therapies for the treatment of Crohn disease (CD), understanding the comparative safety of different therapies can inform treatment positioning.

S Soo-Kyung Park

Dupilumab Beyond the Airway: Decreased Morbidity in a Real-World Analysis

Int Forum Allergy Rhinol. 2026 Feb 6. doi: 10.1002/alr.70111. Online ahead of print.ABSTRACTBACKGROUND: Post hoc analyses of clinical trials have characterized dupilumab's adverse effects, yet the real-world impact in chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma is not well described

E Emma J Anisman